PRKAG2 syndrome is an autosomal dominant Atrium Therapeutics has received clearance from the US Food and Drug Administration ...

Residents are being asked for their views on a proposed £30m council facility including a recycling centre and bin lorry ...

ATR 1072 is the company's first precision cardiology program to enter the clinic -- -- Corventis™ will be the first clinical trial for people living with PRKAG2 syndrome that evaluates a potential ...

In an interview with Fortune India, Daisy Chittilapilly, said why India has become a strategic hub for Cisco, the company's ...

Vinay Maloo and his son Vaibhav Maloo have built the Enso ecosystem the way certain families build institutions: slowly, ...

Recent evidence on cash transfers and child health is mixed, suggesting that cash transfers may be a necessary but ...

Quantum X Labs Inc. (the "Company") (NASDAQ: QXL) today announced that the CliniQuantum operation, has successfully validated ...

Explore the complex balance of risks and benefits in gene drives, a powerful tool in genetic engineering and disease control.

Fidji Simo, OpenAI's Chief of Product, steps down from full-time role due to worsening chronic illness and will become a part ...

Caitlin McDonald's life was fragile and fleeting. She told her own story in hundreds of videos filmed on her phone.

Kyndryl has introduced a new artificial intelligence (AI) orchestration capability designed to help companies move beyond experimentation and siloed workflows and begin deploying AI agents across ...

Today, the question is no longer whether companies will use artificial intelligence. They are already using it. From customer ...